Cox regression analysis suggested that 26 significant DECRLs were related to the survival of patients with pRCC, among which 10 lncRNAs (RP11-573D15.8, LINC01317, RNF144A-AS1, TFAP2A-AS1, LINC00702, GAS6-AS1, RP11-400K9.4, LUCAT1, RP11-63A11.1, RP11-156L14.1) were enrolled into the risk model to generate a cancer-related lncRNA signature in pRCC for survival prediction. The gene discussed is LUCAT1; the disease is cancer.